Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rang in aandelen #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Aandeelprijs
$2.16
Laatst gesynchroniseerd: 2023-09-08
Marktkapitalisatie
$122.36M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Pardes Biosciences, Inc. (PRDS)

Categorie

Dividendrendementgeschiedenis voor Pardes Biosciences, Inc. (PRDS)
Het dividendrendement (TTM) van Pardes Biosciences, Inc. (aandelsymbool: PRDS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Pardes Biosciences, Inc. (PRDS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH